Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ Platform TM provides ...
Citi lowered the firm’s price target on American Express (AXP) to $300 from $320 and keeps a Neutral rating on the shares. The firm revised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback